Literature DB >> 10221819

Characteristics of hepatocellular carcinoma presenting with variceal bleeding.

C H Chen1, J C Sheu, G T Huang, H S Lee, P M Yang, J M Wong, D S Chen.   

Abstract

Patients with hepatocellular carcinoma may present with variceal bleeding as the initial symptoms. The aims of this study is to investigate the characteristics of such patients. A total of 1046 hepatocellular carcinoma cases were retrospectively retrieved from our computer records between 1980 and 1993. The medical records and image studies were reviewed. The status of each patient was assessed at the time of presentation. A total of 14 (about 1 %) patients with hepatocellular carcinoma presented with variceal bleeding. Five (36%) did not have past history of liver disease. The tumour size ranged from 2.5 to 11.3 cm. Compared with hepatocellular carcinoma patients not presenting with variceal bleeding, these patients had a higher percentage of portal vein thrombosis (57.1 vs 19.4%). In two patients, the hepatic tumours were missed in the initial abdominal sonography. The average survival time was 71 days. Seven patients died within 2 months mainly due to variceal bleeding (41.6%). Variceal bleeding might be a clue to the presence of hepatocellular carcinoma with portal vein thrombosis even in patients without a previous history of liver disease. The tumours in such patients might be the infiltrative type, and thus the portal vein should be carefully worked-up. Overall, these patients have an extremely poor prognosis. In the management of patients with variceal bleeding, the possibility of hepatocellular carcinoma with portal vein thrombosis should not be overlooked, especially in areas where this cancer is prevalent.

Entities:  

Mesh:

Year:  1998        PMID: 10221819     DOI: 10.1111/j.1440-1746.1998.tb00633.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma.

Authors:  Chen-Jung Chang; Ming-Chih Hou; Wei-Chih Liao; Fa-Yauh Lee; Han-Chieh Lin; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2012-01-06       Impact factor: 7.527

2.  Improving prognosis following a first variceal haemorrhage over four decades.

Authors:  P A McCormick; C O'Keefe
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

3.  Isolated duodenal varices as the initial presentation of hepatocellular carcinoma.

Authors:  Amara Okoli; Pascale Raymond; Nischala Ammannagari; Nancy Merrell
Journal:  BMJ Case Rep       Date:  2013-12-17

4.  Variceal bleeding caused by oesophageal varices: A manifestation of hepatocellular carcinoma in a 17-year-old girl.

Authors:  Saadia Sasha Ali; Samuel N Sanmuganathan
Journal:  SAGE Open Med Case Rep       Date:  2015-12-24

5.  Predictors of In-Hospital Mortality in patients with hepatocellular carcinoma and Acute Variceal bleeding.

Authors:  Moataz Hassanien; Mohamed Darwish El-Talkawy; Maged El-Ghannam; Ahmed El Ray; Abdel Aziz Ali; Hoda Abu Taleb
Journal:  Electron Physician       Date:  2015-10-19

6.  Deal a death blow! HCC in cirrhotics - thrombotic complications: their frequency, characteristics, and risk factors.

Authors:  Khalid Mahmood; Iftikhar Haider Naqvi; Aamer Mahmood; Syed Muhammad; Noor Muhammad
Journal:  Prz Gastroenterol       Date:  2018-03-26

7.  Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.

Authors:  Zhaohui Bai; Bimin Li; Su Lin; Bang Liu; Yiling Li; Qiang Zhu; Yunhai Wu; Yida Yang; Shanhong Tang; Fanping Meng; Yu Chen; Shanshan Yuan; Lichun Shao; Xingshun Qi
Journal:  Adv Ther       Date:  2019-09-11       Impact factor: 3.845

8.  Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study.

Authors:  Seongman Bae; Taeeun Kim; Min-Chul Kim; Yong Pil Chong; Sung-Han Kim; Heungsup Sung; Young-Suk Lim; Sang-Oh Lee; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  BMC Infect Dis       Date:  2016-06-07       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.